DUALITYBIO-B(09606): The Shanghai Stock Exchange has accepted the application materials for the issuance of RMB shares.

date
22:30 12/06/2026
avatar
GMT Eight
Ying En Biology-B (09606) announced that the company has submitted application materials related to the issuance of RMB shares to the Shanghai Stock Exchange, including the prospectus for the initial public offering of RMB ordinary shares (A shares) and listing on the science and technology innovation board, and has recently received a receipt of acceptance from the Shanghai Stock Exchange for the company's application for the issuance of RMB shares. The prospectus for A shares will be published on the Shanghai Stock Exchange website (http://www.sse.com.cn).
DUALITYBIO-B (09606) Announces that the company has submitted the application materials for the issuance of Renminbi shares to the Shanghai Stock Exchange, including the prospectus for the initial public offering of Renminbi ordinary shares (A shares) and listing on the Sci-Tech Innovation Board, and has recently received the acknowledgement from the Shanghai Stock Exchange regarding the company's application for the issuance of Renminbi shares. The A share prospectus will be published on the Shanghai Stock Exchange website (http://www.sse.com.cn).